Clinical utility of Circulating Long Non-Coding RNAs in indeterminate thyroid nodules.
A blood-based test using a single marker shows promise for clarifying uncertain thyroid nodules without requiring surgery.
This prospective single-center diagnostic validation study evaluated Clinical utility of Circulating Long Non-Coding RNAs in indeterminate thyroid nodules. The PubMed abstract reports that in the Bethesda III/IV validation cohort, only PVT1 retained diagnostic utility, with 76% sensitivity, 87;5% specificity, 85% positive predictive value, and 80% negative predictive value, whereas MALAT1 and BANCR did not demonstrate significant diagnostic performance.
What the study was
- Study design
- Prospective single-center diagnostic validation study
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Endocrine-related cancer
Why it surfaced
Prospective single-center diagnostic validation study with abstract-backed evidence relevant to Early cancer detection (liquid biopsy, ctDNA, cfDNA); the score reflects study maturity, clinical relevance, and population or unmet-need considerations.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.